Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVidendum Plc Regulatory News (VID)

Share Price Information for Videndum Plc (VID)

Share Price is delayed by 15 minutes
Get Live Data
377.50    -14.50 (-3.70%)
Bid:
375.00
Ask:
380.00
Spread: 5.00 (1.333%)
Market Cap: £157.95m
VID Live PriceLast checked at - London Stock Exchange

Intraday Videndum Plc Share Chart

Block listing Interim Review

20 May 2024 11:45

RNS Number : 1219P
Videndum PLC
20 May 2024
 

Videndum plc

BLOCKLISTING INTERIM REVIEW - SIX MONTHLY RETURN

Date:

20 May 2024

Name of applicant:

Videndum plc

Name of scheme:

Videndum 2011 UK Sharesave Scheme

Period of return:

 

 

From:

20 November 2023

To:

19 May 2024

Balance of unallotted securities under scheme(s) from previous return:

2,279

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

2,279

Name of scheme:

Videndum 2011 International Sharesave Plan

Period of return:

 

 

From:

20 November 2023

To:

19 May 2024

Balance of unallotted securities under scheme(s) from previous return:

13,119

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

13,119

Name of scheme:

Videndum 2020 UK Sharesave Plan

Period of return:

 

 

From:

20 November 2023

To:

19 May 2024

Balance of unallotted securities under scheme(s) from previous return:

159,892

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

159,892

Name of scheme:

Videndum 2020 International Sharesave Plan

Period of return:

 

 

From:

20 November 2023

To:

19 May 2024

Balance of unallotted securities under scheme(s) from previous return:

206,642

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

2,273

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

204,369

 

 

 

 

Name of contact:

Jon Bolton

Telephone number of contact:

020 8332 4600

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRAMMMTMTJTBFI
Date   Source Headline
8th Dec 202311:30 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20231:04 pmRNSResults of Capital Raising and General Meeting
5th Dec 20233:31 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSTotal Voting Rights
21st Nov 202312:56 pmRNSPublication of Prospectus
21st Nov 20237:00 amRNSCompletion of Bookbuild
20th Nov 20235:27 pmRNSProposed Capital Raising
20th Nov 20237:00 amRNSBlock listing Interim Review
9th Nov 20237:00 amRNSAppointment of Director & Chairman Designate
8th Nov 20239:56 amRNSGraham Oldroyd change of role
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSDirectorate Change
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
9th Oct 202310:00 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSDirector/PDMR Shareholding
2nd Oct 202312:45 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:35 pmRNSTotal Voting Rights
26th Sep 20237:00 amRNSDirectorate Change
26th Sep 20237:00 amRNSVidendum plc - 2023 Interim Results
25th Sep 20234:37 pmRNSRevised publication date of 2023 Interim Results
14th Sep 202312:00 pmRNSBlocklisting Application for Sharesave and LTIP
1st Sep 20237:00 amRNSTotal Voting Rights
31st Aug 20234:47 pmRNSHolding(s) in Company
24th Aug 202310:57 amRNSHolding(s) in Company
9th Aug 20234:33 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSRevision of Half Year Results Date
1st Aug 20237:00 amRNSTotal Voting Rights
27th Jul 202311:30 amRNSNew directorship held in another UK plc
30th Jun 20232:00 pmRNSTotal Voting Rights
19th Jun 20235:11 pmRNSHolding(s) in Company
1st Jun 20238:47 amRNSTotal Voting Rights
19th May 20238:00 amRNSBlock listing Interim Review
11th May 20231:09 pmRNSResult of 2023 Annual General Meeting
9th May 202310:45 amRNSDirector/PDMR Shareholding
2nd May 20233:14 pmRNSUpdate Announcement
2nd May 20239:49 amRNSTotal Voting Rights
19th Apr 20235:05 pmRNSHolding(s) in Company
13th Apr 20234:15 pmRNSNew directorship held in another public company
4th Apr 202312:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSAnnual Report & Accounts and Notice of 2023 AGM
10th Mar 20239:24 amRNSHolding(s) in Company
3rd Mar 202311:15 amRNSDirector/PDMR Shareholding
1st Mar 202311:03 amRNSTotal Voting Rights
28th Feb 20237:00 amRNS2022 Full Year Results
1st Feb 20239:00 amRNSTotal Voting Rights
3rd Jan 202310:30 amRNSTotal Voting Rights
14th Dec 20227:00 amRNSBoard changes
5th Dec 202210:16 amRNSHolding(s) in Company
1st Dec 20221:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.